MedPath

The effects of reducing worry in patients with persecutory delusions: finding out if worries can be reduced by brief cognitive therapy

Not Applicable
Completed
Conditions
Persecutory delusions in the context of schizophrenia or related diagnosis
Mental and Behavioural Disorders
Schizophrenia or related diagnosis
Registration Number
ISRCTN23197625
Lead Sponsor
The Efficacy and Mechanism Evaluation Programme (MRC/NIHR) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
150
Inclusion Criteria

1. A current persecutory delusion as defined by Freeman and Garety (2000); scoring at least 3 on the conviction scale of the PSYRATS (Haddock et al, 1999)
2. That the delusion has persisted for at least one month
3. A clinical diagnosis of schizophrenia, schizoaffective disorder or delusional disorder (i.e. diagnosis of non-affective psychosis (F2) in the International Classification of Diseases and Diagnostic and Statistical Manual IV)
4. A clinically significant level of worry, as indicated by scores above 44 on the Penn State Worry Questionnaire (see Startup and Erickson, 2006)
5. Aged between 18 and 65
6. Where major changes in medication are being made, entry to the study would not occur until at least a month after stabilisation of dosage

Exclusion Criteria

1. A primary diagnosis of alcohol or substance dependency
2. Organic syndrome or learning disability
3. A command of spoken English inadequate for engaging in therapy
4. Currently having individual cognitive behavioural therapy (CBT) (though previous CBT experience is not an exclusion)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Penn State Worry Questionnaire (PSWQ; Meyer et al, 1990)<br>2. Psychotic Symptoms Rating Scale - Delusions (PSYRATS; Haddock et al, 1999)
Secondary Outcome Measures
NameTimeMethod
1. Paranoid Thoughts Scale (Green et al, 2008)<br>2. Positive and Negative Symptom Scale (PANSS; Kay, 1991).<br>3. EQ-5D (Brooks et al, 2003)
© Copyright 2025. All Rights Reserved by MedPath